ICLR · Icon PLC
$172.23
-2.04 (-1.17%)
At close · Aug 21
Market Cap
$13.29B
Shares
77.15M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$8.25B
+0.8%
FY2025
Net Income
$229.34M
-69%
FY2025
Gross Margin
28.62%
-0.4pp
FY2024
Operating Margin
5.37%
-7.2pp
FY2025
Diluted EPS
$2.90
-67.4%
FY2025
Operating Cash Flow
$1.04B
-19.5%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $8.29B | $8.25B | $8.19B | $8.05BG | $7.74B | $5.48B | $2.8B | $2.81B | $2.6B | $1.76B | $1.67B | $1.57B | $1.5B | $1.34B | $1.12B | $945.73M | $900.04M | $887.61M | $865.25M | |
| — | — | $5.85B | $5.72B | $5.53B | $3.97B | $1.98B | $1.97B | $1.82B | $1.03B | $961.33M | $908.98M | $903.17M | $845.41M | $717.75M | $611.92M | $541.39M | $507.78M | $489.24M | |
| — | — | $2.34B | $2.33B | $2.21B | $1.51B | $817.41M | $831.7M | $777.56M | $731.13M | $705.15M | $666M | $600.15M | $490.65M | $397.26M | $333.81M | $358.66M | $379.83M | $376.01M | |
| — | — | 28.62% | 28.99% | 28.6% | 27.52% | 29.22% | 29.64% | 29.95% | 41.58% | 42.31% | 42.29% | 39.92% | 36.72% | 35.63% | 35.3% | 39.85% | 42.79% | 43.46% | |
| $771.67M | $780.14M | $728.35M | $768.56M | $778.75M | $585.33M | $342.45M | $332.66M | $325.79M | $323.74M | $325.73M | $326.79M | $336.46M | $313.93M | $280.78M | $255.86M | $232.69M | $230.91M | $248.78M | |
| $209.6M | $227.2M | $350.3M | $459.9M | $463.1M | $239.5M | $19.23M | $15.95M | $15.35M | $17.86M | $17.45M | $17.47M | $10.34M | $7.54M | $7.61M | $4.65M | $2.45M | — | — | |
| $370.42M | $383M | $488.5M | $585.95M | $569.51M | $314.99M | $66.13M | $61.55M | $65.92M | $61.3M | $59.58M | $57.68M | $52.54M | $46.51M | $42.82M | $38.68M | $33.87M | $32.66M | $27.73M | |
| — | $75.39M | $76.39M | $36.7M | $4.36M | $11.27M | $18.09M | $0 | $12.49M | $7.75M | $8.16M | $0 | $8.8M | $9.03M | $4.53M | $9.82M | — | $13.3M | — | |
| $8B | $7.81B | $7.16B | $7.15B | $6.95B | $5.1B | $2.41B | $2.37B | $2.22B | $1.42B | $1.35B | $1.29B | $1.3B | $1.21B | $1.05B | $916.29M | $807.95M | $780.16M | $765.74M | |
| $296.5M | $442.85M | $1.03B | $904.66M | $795.24M | $378.53M | $391.5M | $433.41M | $373.36M | $338.34M | $311.69M | $281.54M | $202.35M | $121.17M | $68.02M | $29.44M | $92.1M | $107.45M | $99.5M | |
| — | 5.37% | 12.61% | 11.23% | 10.27% | 6.91% | 14% | 15.45% | 14.38% | 19.24% | 18.7% | 17.88% | 13.46% | 9.07% | 6.1% | 3.11% | 10.23% | 12.11% | 11.5% | |
| $666.92M | $825.84M | $1.52B | $1.49B | $1.36B | $693.52M | $457.63M | $494.96M | $439.27M | $399.64M | $371.27M | $339.21M | $254.89M | $167.68M | $110.84M | $68.13M | $125.97M | $140.11M | $127.23M | |
| $196.51M | $197.49M | $237.24M | $336.7M | $229.73M | $182.42M | $13.02M | $13.28M | — | — | — | — | — | — | — | — | — | — | — | |
| $8.23M | $7.11M | $8.61M | $5.01M | $2.35M | $574K | $2.72M | $6.86M | $4.76M | $2.35M | $1.48M | $1.31M | $1.15M | $986K | $1.15M | $1.19M | $1.76M | $752K | $2.88M | |
| — | $0 | $0 | -$383K | -$3.14M | -$2.16M | -$366K | $0 | $0 | — | — | — | — | — | — | — | — | — | — | |
| — | $252.47M | $803.76M | $572.98M | $567.85M | $196.68M | $381.21M | $426.99M | $364.61M | $328.06M | $300.17M | $278.85M | $202.72M | $120.87M | $67.22M | $29M | $92.72M | $104.67M | $98.28M | |
| $65.87M | $23.13M | $64.63M | $18.39M | $59.41M | $41.33M | $47.88M | $51.13M | $41.96M | $46.57M | $37.99M | $39.31M | $30.25M | $18.05M | $11.8M | $6.12M | $5.65M | $10.38M | $19.97M | |
| $42.34M | $229.34M | $739.13M | $554.21M | $505.3M | $153.19M | $332.33M | $373.99M | $322.66M | $281.49M | $262.18M | $239.54M | $172.47M | $102.81M | $55.42M | $22.88M | $87.07M | $94.3M | $78.12M | |
| — | 2.78% | 9.03% | 6.88% | 6.53% | 2.79% | 11.88% | 13.33% | 12.43% | 16.01% | 15.73% | 15.21% | 11.47% | 7.7% | 4.97% | 2.42% | 9.67% | 10.62% | 9.03% | |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | $193K | |
| — | — | — | — | $505.3M | $153.19M | $327.81M | $368.94M | $322.66M | $281.49M | — | — | — | — | — | — | — | — | — | |
| $1.29M | $390.73M | $652.7M | $582.24M | $424.7M | $97.73M | $372.67M | $367.5M | $292.04M | $329.08M | $237.52M | $215.46M | $132.95M | $113.55M | $63.09M | $6.04M | $74.88M | $103.71M | $49.47M | |
| USD/shares | — | $2.92 | $8.96 | $6.75 | $6.20 | $2.28 | $6.20 | $6.85 | $5.96 | $5.20 | $4.75 | $4.08 | $2.80 | $1.69 | $0.92 | $0.38 | $1.46 | $1.61 | $1.34 |
| USD/shares | — | $2.90 | $8.90 | $6.70G | $6.13 | $2.25 | $6.15 | $6.79 | $5.89 | $5.13 | $4.65 | $3.97 | $2.73 | $1.65 | $0.92 | $0.37 | $1.44 | $1.57 | $1.30 |
| shares | — | 78.42M | 82.48M | 82.1M | 81.53M | 67.11M | 52.86M | 53.86M | 54.12M | 54.13M | 55.25M | 58.75M | 61.5M | 60.91M | 59.97M | 60.38M | 59.72M | 58.64M | 58.25M |
| shares | — | 78.97M | 83.03M | 82.72M | 82.47M | 68.07M | 53.28M | 54.33M | 54.79M | 54.85M | 56.41M | 60.29M | 63.13M | 62.25M | 60.45M | 61.07M | 60.64M | 59.9M | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2011–FY2025: $2.67B in buybacks.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
1.90×
Peer median 5.64×
EV/EBIT
53.16×
Peer median 30.25×
P/E (TTM)
264.97×
Peer median 32.10×
Peer medians compare against the 25 similar-size Diagnostics & Research companies (of 49 listed).
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Geography (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Ireland | $3,183,637,000 | $2,703,765,000 | $2,317,527,000 | $1,984,567,000 | $1,365,909,000 | $1,181,292,000 | $1,252,834,000 | $1,066,200,000 |
| United States | $2,524,938,000 | $2,983,052,000 | $3,280,018,000 | $3,574,610,000 | $2,581,007,000 | $925,563,000 | $892,497,000 | $894,978,000 |
| Rest of Europe | $1,590,867,000 | $1,559,532,000 | $1,572,883,000 | $1,618,350,000 | $1,175,515,000 | $416,884,000 | $388,916,000 | $379,883,000 |
| Rest of World | $951,898,000 | $942,641,000 | $884,498,000 | — | — | — | — | — |
| Other Countries | — | — | — | $563,859,000 | $358,395,000 | $273,549,000 | $271,592,000 | $254,716,000 |
Key facts
CIK
1060955
CUSIP
G4705A100
13F (30d)
385 filings
353 filers
Visit website
Investor relations